First Patient Enrolled in ProstACT TARGET Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/14/2026

1. ORCL
2. ADBE
3. SPY
4. RH
5. CPRT
6. ACVA
7. AZN
8. QQQ
9. SEDG
10. TENB

Go back to First Patient Enrolled in ProstACT TARGET Study
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 11.29 --0 (-0%)
Previous Close $11.29    52 Week High $2.18 
Open $11.29    52 Week Low $0.30 
Day High $11.29    P/E N/A 
Day Low $11.29    EPS $-3.32 
Volume 18,307